Women were less than half of the people tested for almost all of these common medicines.

NCT00429273

Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder

See it on ClinicalTrials.gov β†—

207 people

65 womenmiddle line = equal numbers142 men
Phase
PHASE4
Paid for by
University of California, Los Angeles
Finished
2011-07
Health conditions
Attention Deficit Disorder With Hyperactivity
Who could join
Anyone
Ages
7 Years – 14 Years
Average age
mean 10.0 years
Age 65+
Not reported
Weight (BMI)
Not reported
Pregnancy recorded
Not reported
Menopause recorded
Not reported
Results shown by sex
Not split by sex
Race
White 57% Β· Hispanic / Latina 17.5% Β· Black / African American 14.3% Β· Native Hawaiian / Pacific Islander 6.4% Β· Other 4.8%

Women left out

  • Age limit under 65

    Older women were turned away, even though they often take this medicine.

    β€œMaximum age: 14 Years.”
  • No pregnant women

    Women who were pregnant could not join.

    β€œPregnant, breastfeeding, or beyond menarche and has a positive urine pregnancy test”
  • No breastfeeding moms

    Women who were breastfeeding could not join.

    β€œPregnant, breastfeeding, or beyond menarche and has a positive urine pregnancy test”
  • Weight limit (BMI)

    Women with a higher (or lower) body weight were turned away.

    β€œSystolic or diastolic blood pressure at screening greater than the 95th percentile or less than the 5th percentile for age and body mass index (BMI)”
  • No mental health conditions

    Women with depression, bipolar disorder or other mental health conditions were turned away.

    β€œHistory of autism, pervasive developmental disorder, chronic tic disorder, psychosis, or bipolar disorder”

Study titles and rules are shown in their original English.